Triamcinolone and PDT to treat exudative age-related macular degeneration and submacular hemorrhage

European Journal of Ophthalmology

Volumn 16, Issue 3, 2006, Pages 426-434

  Ruiz Moreno, José Ma ^a,c   Montero, J A ^b   Barile, S ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Vitreo Retinal Unit ^*  (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Age related macular degeneration; Intravitreous triamcinolone; Photodynamic therapy; Subretinal hemorrhage

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETINA MACULA HEMORRHAGE; SPAIN; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33745910559     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600311     Document Type: Article

References (40)

1. Leguay J, Gastaud P. Subretinal hematoma in age-related macular degeneration: treatment with intravitreal injection of tPA and gas [in French]. J Fr Ophtalmol 2000; 23: 797-801.
2. Avery RL, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996; 16: 183-9.
3. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982; 94: 762-73.
4. Scheider A, Gundisch O, Kampik A. Surgical extraction of subfoveal choroidal new vessels and submacular haemorrhage in age-related macular degeneration: results of a prospective study. Graefes Arch Clin Exp Ophthalmol 1999; 237: 10-5.
5. Lim JI, Drews-Botsch C, Sternberg P, Jr., Capone A, Jr., Aaberg TM, Sr. Submacular hemorrhage removal. Ophthalmology 1995; 102: 1393-9.
6. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004; 111: 1201-8.
7. Hattenbach LO, Klais C, Koch FH, Gumbel HO. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001; 108: 1485-92.
8. Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement. Arch Ophthalmol 2001; 119: 28-32.
9. Krepler K, Kruger A, Tittl M, Stur M, Wedrich A. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration. Retina 2000; 20: 251-6.
10. Hesse L, Kroll P. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. Adv Ther 1997; 14: 275-80.
11. Hesse L, Schroeder B, Heller G, Kroll P. Quantitative effect of intravitreally injected tissue plasminogen activator and gas on subretinal hemorrhage. Retina 2000; 20: 500-5.
12. Jonas JB, Jager M. Perfluorohexyloctane endotamponade for treatment of subfoveal hemorrhage. Eur J Ophthalmol 2002; 12: 534-6.
13. Daneshvar H, Kertes PJ, Leonard BC, Peyman GA. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study. Can J Ophthalmol 1999; 34: 385-8.
14. Do DV, Bressler NM, Bressler SB. Large submacular hemorrhages after verteporfin therapy. Am J Ophthalmol 2004; 137: 558-60.
15. Rechtman E, Danis RP, Pratt LM, Harris A. Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2004; 88: 344-7.
16. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110: 1517-25.
17. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005; 112: 301-4.
18. Bressler NM, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001; 119: 198-207.
19. Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, Michels SM. Effects of verteporfin therapy on central visual field function. Ophthalmology 2004; 111: 931-9.
20. Bloom SM, Brucker AJ. Laser Surgery of the Posterior Segment. Philadelphia: Lippincott-Raven Publications; 1997; 3-36.
21. Schmidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003; 44: 4473-80.
22. Wang YS, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 2002; 240: 42-8.
23. Ciulla TA, Criswell MH, Danis RP, et al. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br J Ophthalmol 2003; 87: 1032-7.
24. Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye 2005; 19: 163-70.
25. Levine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 2004; 1012: 252-66.
26. Padeh S, Passwell JH. Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 1998; 41: 1210-4.
27. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218-24; discussion 224-5.
28. Majori M, Vachier I, Godard P, et al. Superoxide anion production by monocytes of corticosteroid-treated asthmatic patients. Eur Respir J 1998; 11: 133-8.
29. Dweik RA, Lewis M, Kavuru M, et al. Inhaled corticosteroids and beta-agonists inhibit oxidant production by bronchoalveolar lavage cells from normal volunteers in vivo. Immunopharmacology 1997; 37: 163-6.
30. Fukushima K, Ando M, Ito K, Suga M, Araki S. Stimulus- and cumulative dose-dependent inhibition of O2- production by polymorphonuclear leukocytes of patients receiving corticosteroids. J Clin Lab Immunol 1990; 33: 117-23.
31. Weiner FR, Czaja MJ, Jefferson DM, et al. The effects of dexamethasone on in vitro collagen gene expression. J Biol Chem 1987; 262: 6955-8.
32. Merrill PT, LoRusso FJ, Lomeo MD, et al. Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 1999; 106: 782-9.
33. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999; 106: 1900-6; discussion 1906-7.
34. Steinhorst UH, Theischen M, Winter R. Subretinal lavage: a technique of continuous subretinal irrigation for removal of traumatic submacular hemorrhage. Ophthalmologica 1997; 211: 399-401.
35. Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995; 113: 810-8.
36. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of pre-retinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996; 103: 2099-104.
37. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 90: 810-6.
38. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993; 231: 34-40.
39. Weishaupt K, Gomer C, Dougherty T. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of murine tumor. Cancer Res 1976; 36: 2326-9.
40. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroids. Invest Ophthalmol Vis Sci 2002; 43: 830-41.